近期起病中轴型脊柱关节炎5年随访缓解的相关因素:DESIR队列结果
基于DESIR队列中近期起病中轴型脊柱关节炎患者,分析5年随访时ASDAS-CRP缓解的基线相关因素。449例中111例(25%)达到缓解;从未暴露TNFi者缓解率31%,暴露者17%。基线低BASDAI、外周关节炎史、较高教育水平、较低BMI及较低附着点炎指数与5年缓解相关,且按TNFi暴露分层后关联不同。
要点
- 近期起病axSpA患者5年缓解率为25%,从未暴露TNFi者缓解率高于暴露者。
- 从未暴露TNFi者中,基线较低BASDAI和外周关节炎史与5年缓解独立相关。
- 暴露TNFi者中,较高教育水平、较低附着点炎指数、较低BASDAI和较低BMI与缓解相关。
核心结论
- 近期起病axSpA患者5年缓解率不高,即使使用TNFi,活动度较高者仍难以达到缓解。
- 社会经济因素和BMI与5年缓解结局相关。
研究设计与样本
- DESIR队列中近期起病axSpA患者,纳入5年随访时具有ASDAS-CRP数据的患者,按TNFi暴露分层的logistic回归模型。
主要发现
- 449例中111例(25%)在5年随访时处于缓解(ASDAS-CRP<1.3)。
- 从未暴露TNFi者中31%(77/247)缓解,暴露TNFi者中17%(34/202)缓解。
- 5年缓解者更可能为男性、HLA-B27阳性、较低BMI和较高教育水平。
- 从未暴露TNFi者中,基线较低BASDAI(ORa 0.9,95%CI:0.8,0.9)和外周关节炎史(ORa 2.1,95%CI:1.2,5.3)与5年缓解相关。
- 暴露TNFi者中,较高教育水平(ORa 2.9,95%CI:1.6,5.1)、较低附着点炎指数(ORa 0.8,95%CI:0.7,0.9)、较低BASDAI(ORa 0.9,95%CI:0.9,0.9)和较低BMI(ORa 0.8,95%CI:0.7,0.9)与5年缓解相关。
关键数值与推荐
- 缓解定义为ASDAS-CRP<1.3。
临床怎么用
- 对近期起病axSpA患者,基线低疾病活动度、外周关节炎史、较高教育水平、较低BMI和较低附着点炎指数可能提示5年缓解可能性较高。
- TNFi暴露与否影响基线因素与5年缓解的关联,临床评估预后时需考虑治疗暴露状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The factors contributing to long-term remission in axial SpA (axSpA) are unclear. We aimed to characterize individuals with axSpA at the 5-year follow-up to identify baseline factors associated with remission. METHODS: We included all patients from the DESIR cohort (with recent-onset axSpA) with an available Ankylosing Spondylitis Disease Activity Score-CRP (ASDAS-CRP) at 5-year follow-up. Patients in remission (ASDAS-CRP < 1.3) were compared with those with active disease by demographic, clinical, biological and imaging characteristics. A logistic model stratified on TNF inhibitor (TNFi) exposure was used. RESULTS: Overall, 111/449 patients (25%) were in remission after 5 years. Among those never exposed to TNFi, 31% (77/247) were in remission compared with 17% (34/202) of those exposed to TNFi. Patients in remission after 5 years were more likely to be male, HLA-B27+, have a lower BMI, and a higher education level. Baseline factors associated with 5-year remission in patients never exposed to TNFi included lower BASDAI [adjusted odds ratio (ORa) 0.9, 95% CI: 0.8, 0.9) and history of peripheral arthritis (ORa 2.1, 95% CI: 1.2, 5.3). In those exposed to TNFi, remission was associated with higher education level (ORa 2.9, 95% CI: 1.6, 5.1), lower enthesitis index (ORa 0.8, 95% CI: 0.7, 0.9), lower BASDAI (ORa 0.9, 95% CI: 0.9, 0.9) and lower BMI (ORa 0.8, 95% CI: 0.7, 0.9). CONCLUSION: This study highlights the difficulty in achieving 5-year remission in those with recent-onset axSpA, especially for the more active cases, despite the use of TNFi. Socio-economic factors and BMI are implicated in the outcome at 5 years.
引用
- Pina Vegas L, Sbidian E, Wendling D, et al. Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort. Rheumatology (Oxford). 2022. PMID: 34270707. doi:10.1093/rheumatology/keab565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。